LIXT icon

Lixte Biotechnology
LIXT

Overview Fund Activity

6 hedge funds and large institutions have $285K invested in Lixte Biotechnology in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
HighTower Advisors
1
HighTower Advisors
Illinois
$234K
2
Morgan Stanley
2
Morgan Stanley
New York
$33.4K
3
TRCT
3
Tower Research Capital (TRC)
New York
$5.26K
4
FIA
4
FNY Investment Advisers
New York
$12K
5
UBS Group
5
UBS Group
Switzerland
$7

Top Sellers

1
EFG
1
Ethos Financial Group
Pennsylvania
$0
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
HighTower Advisors
1
HighTower Advisors
Illinois
$234K 99,432 +99,432 New
Morgan Stanley
2
Morgan Stanley
New York
$33.4K 14,212 +7,106 +100%
FIA
3
FNY Investment Advisers
New York
$12K 5,500 +500 +10%
TRCT
4
Tower Research Capital (TRC)
New York
$5.26K 2,239 +1,180 +111%
Wells Fargo
5
Wells Fargo
California
$21 9 – –
UBS Group
6
UBS Group
Switzerland
$7 3 +3 New
EFG
7
Ethos Financial Group
Pennsylvania
– – -24,808 Closed
JPMorgan Chase & Co
8
JPMorgan Chase & Co
New York
– – -1 Closed
CFGS
9
Concourse Financial Group Securities
Alabama
– – – –